4.7 Article

Hyaluronic acid modified covalent organic polymers for efficient targeted and oxygen-evolved phototherapy

Journal

JOURNAL OF NANOBIOTECHNOLOGY
Volume 19, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s12951-020-00735-x

Keywords

Targeted therapy; Photothermal therapy; Photodynamic therapy; Covalent organic polymers; Hypoxia tumor

Funding

  1. National Natural Science Foundation of China [81773277]
  2. Science and Technology Program of Guangzhou [201803010014]

Ask authors/readers for more resources

The study demonstrates the development of an organic nanoagent with oxygen-evolved and targeted ability for improved phototherapeutic efficacy. The nanoagent shows catalase-like activity in the presence of hydrogen peroxide and improved generation of reactive oxygen species under near-infrared laser irradiation. Targeted uptake in tumor cells and superior phototherapeutic efficacy over non-targeted counterparts are confirmed in vitro and in vivo.
The integration of multiple functions with organic polymers-based nanoagent holds great potential to potentiate its therapeutic efficacy, but still remains challenges. In the present study, we design and prepare an organic nanoagent with oxygen-evolved and targeted ability for improved phototherapeutic efficacy. The iron ions doped poly diaminopyridine (FeD) is prepared by oxidize polymerization and modified with hyaluronic acid (HA). The obtained FeDH appears uniform morphology and size. Its excellent colloidal stability and biocompatibility are demonstrated. Specifically, the FeDH exhibits catalase-like activity in the presence of hydrogen peroxide. After loading of photosensitizer indocyanine green (ICG), the ICG@FeDH not only demonstrates favorable photothermal effect, but also shows improved generation ability of reactive oxygen species (ROS) under near-infrared laser irradiation. Moreover, the targeted uptake of ICG@FeDH in tumor cells is directly observed. As consequence, the superior phototherapeutic efficacy of the targeted ICG@FeDH over non-targeted counterparts is also confirmed in vitro and in vivo. Hence, the results demonstrate that the developed nanoagent rationally integrates the targeted ability, oxygen-evolved capacity and combined therapy in one system, offering a new paradigm of polymer-based nanomedicine for tumor therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available